20.28
+0.42
+(2.11%)
At close: 4:00:00 PM EST
20.28
0.00
(0.00%)
After hours: 4:00:21 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-48,458.00
-43,699.00
-36,068.00
Investing Cash Flow
-135,013.00
27,352.00
-29,263.00
Financing Cash Flow
180,375.00
31.00
110,855.00
End Cash Position
36,711.00
39,483.00
55,799.00
Capital Expenditure
--
-1,116.00
-1,874.00
Issuance of Capital Stock
181,328.00
--
110,791.00
Free Cash Flow
-48,580.00
-44,815.00
-37,942.00
12/31/2022 - 2/7/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAZE Maze Therapeutics, Inc.
11.32
-5.51%
MTSR Metsera, Inc.
30.03
-5.12%
ALMS Alumis Inc.
5.10
+1.39%
ANAB AnaptysBio, Inc.
19.29
+19.44%
THRD Third Harmonic Bio, Inc.
3.4300
-3.38%
MBX MBX Biosciences, Inc.
8.99
-0.33%
SLRN Acelyrin, Inc.
2.0600
+3.00%
BCAX Bicara Therapeutics Inc.
13.12
-0.76%
UPB Upstream Bio, Inc.
7.33
+2.37%
PLRX Pliant Therapeutics, Inc.
3.2900
+20.96%